Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

L-Fucose

    • Product Name L-Fucose
    • Alias 6-Deoxy-L-galactose
    • Einecs 212-964-7
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    491163

    Cas Number 2438-80-4
    Molecular Formula C6H12O5
    Molecular Weight 164.16 g/mol
    Synonyms 6-Deoxy-L-galactose
    Appearance White to off-white crystalline powder
    Solubility In Water Freely soluble
    Melting Point 128-130°C
    Specific Rotation [α]D20 +18° (c=1, H2O)
    Purity Typically ≥99%
    Storage Conditions Store in a cool, dry place, tightly closed
    Ph Of 1 Solution 4.0-6.0
    Chemical Class Monosaccharide
    Origin Naturally occurring in human milk and plant cell walls
    Identification Methods HPLC, NMR, MS

    As an accredited L-Fucose factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 25g of L-Fucose is packaged in a sealed, amber glass bottle with a secure screw cap, labeled with product and safety information.
    Shipping L-Fucose is shipped in secure, tightly sealed containers to prevent contamination and moisture exposure. Packaging complies with relevant safety and regulatory standards for non-hazardous chemicals. The product is typically transported at room temperature and labeled with proper identification for safe handling during transit. Expedited shipping options are available upon request.
    Storage L-Fucose should be stored in a cool, dry, and well-ventilated area, away from incompatible substances. It is best kept in a tightly closed container, protected from moisture and direct sunlight. The recommended storage temperature is 2–8 °C (refrigerated). Ensure proper labeling and avoid exposure to excessive heat or humidity to maintain its stability and quality.
    Application of L-Fucose

    Applications of L-Fucose in Industrial Manufacturing

    L-Fucose, a naturally occurring monosaccharide, supports advanced manufacturing processes across specialized biotechnology, medical, food, and cosmetic sectors. As a direct producer, we supply high-purity L-Fucose used by industry leaders for innovative downstream applications with confirmed regulatory acceptance and established process integration. Below, we outline proven industrial scenarios—each reflecting distinct product requirements, regulatory frameworks, and formula specification needs.

    1. Human Milk Oligosaccharides (HMO) Production for Infant Nutrition

    Leading producers of infant formula and baby nutrition incorporate L-Fucose as a key precursor in enzymatic synthesis of human milk oligosaccharides, notably 2’-Fucosyllactose (2’-FL) and 3-Fucosyllactose (3-FL). These HMOs mimic the functional prebiotics in human breast milk, supporting gut microbiota and immune development in infants. Manufacturers must conform to food safety and infant formula-specific guidelines, with L-Fucose introduced during the upstream glycosylation stage to enable targeted oligosaccharide chain assembly.

    Industry compliance standards

    • Codex Alimentarius Standard 72-1981 (Infant Formula)
    • EU Regulation (EU) 2016/127 on Infant Formula and Follow-on Formula
    • FDA GRAS Notice (GRN No. 650 for 2’-FL)
    • ISO 22000 Food Safety Management Systems

    Typical usage ratio

    • Fucose addition in enzymatic synthesis: 2%–8% w/w of carbohydrate raw mix, adjusted based on target oligosaccharide profile and scalability validations

    Downstream process integration

    • L-Fucose added to fermentation or enzymatic reactor following preparation of lactose-based substrate; precise pH and temperature controls maintained for glycosyltransferase activity; subsequent purification to isolate 2’-FL or 3-FL

    Final product types

    • Infant formula powder (with added HMOs)
    • Liquid infant nutritional supplements
    • Prebiotic syrup blends
    • Specialty pediatric nutrition ingredients

    2. Glycoprotein Therapeutics Manufacturing

    Biopharmaceutical industries use L-Fucose in recombinant cell culture media to enhance targeted fucosylation during glycoprotein biosynthesis, notably in monoclonal antibodies (mAbs) and therapeutic enzymes. Fucose modulation in the culture process influences key pharmacokinetic properties such as antibody-dependent cell-mediated cytotoxicity (ADCC). Compliance with therapeutic ingredient standards and GMP is mandatory, with fucose added at regulated concentrations to suit cell-line specific profiles.

    Industry compliance standards

    • ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
    • U.S. Pharmacopeia (USP) General Chapter <797>
    • European Pharmacopoeia (Ph. Eur.) for Biological Medicinal Products
    • FDA 21 CFR Parts 210 & 211

    Typical usage ratio

    • Addition to cell culture/bioreactor feed: 0.05–0.2 g/L, adjusted according to cell type (CHO, HEK293), process stage, and glycosylation target specification

    Downstream process integration

    • L-Fucose is dosed into media during mid-exponential or fed-batch phase in cell culture, directly influencing N-glycan structure of secreted proteins; final monoclonal antibodies or enzymes undergo purification and QC analysis for fucosylation levels

    Final product types

    • Therapeutic monoclonal antibodies
    • Recombinant biopharmaceutical enzymes
    • Fucosylated glycoprotein APIs
    • Cell therapy media components

    3. Prebiotic and Functional Food Ingredient Formulation

    Food manufacturers seeking to introduce scientifically-backed prebiotics within products such as health drinks, yogurt, and nutritional bars use L-Fucose as a specialty carbohydrate. Its fermentative properties enhance gut microbiome diversity, with addition governed by food additive statutes and local market requirements. During blending or extrusion, L-Fucose is dosed with precision to align with finished-product claims and labelling compliance, while ensuring product stability.

    Industry compliance standards

    • EU Regulation (EC) No 1333/2008 on Food Additives
    • U.S. FDA 21 CFR Part 172 – Food Additives Permitted for Direct Addition to Food for Human Consumption
    • GB 2760-2024 Standard for Food Additive Use (China)
    • FSSC 22000 Certification Scheme

    Typical usage ratio

    • Direct addition: 0.1%–2.0% w/w in finished food items; dosage set by national regulation and specific functional claim (digestive, immune)

    Downstream process integration

    • Blending in dry powder mixtures, direct dosing into beverage bases or fermented dairy process tanks, or post-pasteurization addition in ready-to-eat foods under aseptic conditions

    Final product types

    • Functional beverages (probiotic drinks)
    • Yogurts and fermented dairy products
    • Nutritional and snack bars
    • Prebiotic capsule supplements

    4. Advanced Cosmetic Formulations

    Dermocosmetic and skin care brands integrate L-Fucose into high-end cosmetic formulations to support skin cell communication and barrier repair functions. Application includes anti-aging creams and advanced serums, where clinical studies support benefits on skin hydration and sensitivity management. Cosmetic GMP and regional legislation on ingredient safety guide the incorporation process, with precise fucose levels calculated for stability and efficacy in topical delivery systems.

    Industry compliance standards

    • EU Cosmetic Regulation (EC) No 1223/2009
    • ISO 22716:2007 Good Manufacturing Practices (GMP) for Cosmetics
    • U.S. FDA Voluntary Cosmetic Registration Program (VCRP)
    • China NMPA Cosmetic Ingredient Catalogue

    Typical usage ratio

    • Formulation addition: 0.05%–1.5% w/w depending on product type (serum, cream, gel) and clinical validation requirements

    Downstream process integration

    • L-Fucose introduced at emulsification or solubilization stage, typically during cooling cycle post-emulsification to prevent thermal degradation; QA validation checks performed through stability and compatibility testing with bioactives

    Final product types

    • Anti-aging facial creams and serums
    • Soothing skin barrier repair lotions
    • High-performance cosmetic gels for sensitive skin
    • Post-procedure dermatological topical formulations

    5. Diagnostic Glycan Standard Production

    IVD (in vitro diagnostics) supply chains demand purified L-Fucose as a calibration glycan or as a substrate for quantification assays detecting specific fucosylated biomarkers in blood or plasma. Diagnostic reagent producers operate under strict ISO and medical device quality frameworks, with fucose used in both kit manufacture and automated analyzer calibration routines to standardize glycan measurement outputs.

    Industry compliance standards

    • ISO 13485:2016 Quality Management for Medical Devices
    • U.S. FDA 21 CFR Part 820 (QSR for Medical Devices)
    • IVDR Regulation (EU) 2017/746 on In Vitro Diagnostic Devices
    • CLSI (Clinical Laboratory Standards Institute) Guidelines

    Typical usage ratio

    • Assay calibration: typically 1–20 µg/test, with batchwise preparation based on diagnostic kit production volume

    Downstream process integration

    • L-Fucose dissolved and prepared as glycan standard or substrate at the assay formulation stage; aliquoted into IVD kit vials and lyophilized for shelf stability; integrated into assay panels and autoanalyzer cartridges

    Final product types

    • IVD biomarker assay kits (e.g. cancer, liver disease detection)
    • Laboratory calibration reference materials
    • Automated analyzer glycan panels
    • Quantitative glycan assay kits
    Free Quote

    Competitive L-Fucose prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    L-Fucose: Reliable Performance from the Source

    What L-Fucose Brings to the Table

    Day after day, our teams watch L-Fucose work its way through production—every batch a testament to chemical accuracy and care. As a monosaccharide, this sugar stands out in both structure and function. Years of hands-on experience have taught us not only its critical biological roles, but also the importance of tight control over process conditions. We frequently see L-Fucose in demand for cell biology studies, glycoprotein research, and even select nutrient applications. Its special place in glycosylation makes it more than just a building block; it turns into a bridge, letting researchers open new chapters in glycoscience. These qualities reflect in how end-users rely on it for exact glycan mapping or precise metabolic experiments.

    Our product stems directly from fermentation routes. This direct method delivers high purity and batch consistency, which rules out headaches over interference from synthetic byproducts. Purity isn’t a slogan here. We stick with high-purity grades, supporting confirmed levels by HPLC and NMR. Our batches usually maintain L-Fucose content above 98 percent, with residual moisture down in the single digits. Our powder shows off with the familiar white to off-white look, completely soluble in water—an asset in both laboratory and industrial formulations.

    It’s not just the numbers or the color that make L-Fucose tick. On the production floor, batch integrity depends on closely managed temperatures, tight timelines, and thorough documentation. Our QA team holds nothing back. Every release passes microbial and heavy metal screens, lining up with leading pharmaceutical and life sciences requirements. This isn’t just to check boxes for compliance; consistent process conditions cut risks, raise reproducibility, and keep customer outcomes predictable.

    Decades of practice have shaped how we address questions from bio-industry researchers and formulation engineers. Many users work with other sugars—mannose, galactose, or rhamnose. These are decent in their own right but carry distinct roles; few can replicate the particular recognition properties that L-Fucose offers for bacterial adhesion, select immunological signals, or human milk oligosaccharide studies. Glycobiologists often point out that the structure of L-Fucose—a six-carbon deoxyhexose lacking the C-6 hydroxyl group—answers specific analytical needs where other sugars cannot fit.

    L-Fucose’s value extends into unique downstream contexts. Biopharmaceutical developers have long seen its involvement in the fucosylation of monoclonal antibodies, which alters antibody-dependent cell-mediated cytotoxicity. In technical terms, this helps modulate effector function. It’s not just a matter of plugging in any sugar; using fucose at the key modification step enables new therapeutic properties. The difference becomes obvious in side-by-side cell activity studies, and our product’s batch reliability keeps these complex processes on target, without the setbacks we’ve seen from less controlled materials.

    From an industry standpoint, recurring users tell us that switching suppliers often leads to disappointing shifts in solubility, contamination, or yield. This aligns with our direct feedback: consistency hinges on chemical discipline on the production side, plus the traceability that experienced staff guarantee. There’s no shortcut here—only tight hands-on oversight and full transparency back to each raw material, fermentation batch, and purification step.

    How We Prepare L-Fucose for Complex Purposes

    Working closely with enzyme manufacturers, we observe how every application of L-Fucose brings unique challenges. Some of our customers push for selective glycoengineering, essentially tuning protein functions by shifting L-Fucose levels in cell culture media. In cases focused on bacterial or mammalian glycan research, our L-Fucose supports cell growth experiments and helps dissect cell membrane interactions. Because our batches roll out with minimal endotoxin levels, downstream researchers avoid shortcuts in their own QC, and often bypass unnecessary purification steps in their workflow.

    Pharmaceutical-grade purity matters even more in clinical or diagnostic research. Years ago, some labs experimented with chemically synthesized or unrefined sugars. Results scattered all over the map, inviting questions over contamination and stability. The scene looks different today. High-quality L-Fucose underpinned by strong documentation, real test data, and hands-on support delivers the shelf stability and reliable handling required for regulated applications.

    Our technical teams remember plenty of days spent adjusting agitation, pH, and oxygenation, all in pursuit of a batch that matches the previous run. Fermentation isn’t a one-button push—deep knowledge of strain selection, media optimization, and scale-up logistics runs through our entire operation. Our regular maintenance intervals, robust CIP, and validated filtration all keep impurities at bay, while our release protocols—built on in-house and third-party testing—give customers full trust in what they’re handling.

    We see engineers using L-Fucose in more inventive ways every year. As analytical standards evolve for high-throughput glycan profiling, researchers want clean, traceable reference compounds. We support this shift with detailed documentation: traceable certificates of analysis, shipping records, and stability data. For scale-up or commercial production, solid predictability holds equal importance, because even a half percent deviation in purity tosses off downstream reactions. Knowing that our batches come from seasoned hands lets formulators move quickly, with fewer downtimes and less off-spec product.

    What separates L-Fucose from its close relatives emerges under the microscope and in the reaction flask. Its structural distinction—lacking that specific hydroxyl group—translates into different binding behaviors with lectins, and often, unique results in immunoassays or diagnostic microarrays. Other sugars can mimic parts of these patterns, but often fail to generate the desired biological signals or specificity in complex glycomics projects. Our L-Fucose keeps cross-reactivity to a minimum, reducing noise and supporting sharper scientific answers.

    Quality Never a Footnote

    Any reputable manufacturer lives and breathes by their audit trails and documentation. Our team has responded to enough customer audits to expect the full battery: traceability through every drum, evidence of GMP compliance, batch chromatography records, validation of residual solvents and heavy metals, managerial sign-off on every lot. Partners in clinical labs aren’t interested in vague assurances—they have seen erratic sugars disrupt experiments and diagnostic tests. Our documentation closes that gap. Each box that leaves our warehouse carries both the physical product and the proof behind its claims.

    Quality control in our house doesn’t pencil in shortcuts for cost or speed. Instead, the process includes multiple checkpoints. We run tight controls from raw material selection straight through fermentation, downstream purification, and final drying. Chromatographic profiles confirm chemical identity long before a batch reaches QA. Past experience taught us where the pitfalls hide—stray carbohydrate impurities lead to false positives, metallic residues can damage cells or alter assay readouts, and dry blends prone to caking disrupt automated handling. Our solutions follow from persistent vigilance: moisture control, inert-atmosphere packaging, and temperature-monitored shipping mean fewer surprises in your lab or plant.

    Stakeholders—whether running production or running compliance—call for transparency, reliability, and available support. Our response rests in clear supply chain routes, visible batch records, expedited testing, and response-ready technical teams. If a researcher or plant manager needs to track the fingerprint of L-Fucose back through the process, our support picks up instantly, pulling up MSDS, CoA, and archived test runs. Open lines of communication prevent costly missteps, and our staff take pride in walking customers through every aspect of their order.

    L-Fucose in Practical Manufacturing Environments

    On the shop floor or in a high-throughput lab, time blocks for preparation and cleanup shrink every season. That’s one of the reasons our customers prefer a product with smooth-flowing, low-caking properties. Each bag pours directly into solution or pre-mix tanks without leaving residue or clumping. Our team invests in regular blending studies, real-world tests of storage and thaw cycles, and handling trials. Experience taught us that little oversights—improper moisture balance, missed sieve fractions, or rough particle finish—lead to production line headaches. By controlling each variable, we keep downtime in check and batch-to-batch performance steady.

    Tech teams in the lab or on the assembly line often juggle tight project timelines. Every lost hour on failed dissolution or filter blockage adds up. We’ve responded by tuning our drying, grinding, and packing endpoints to strike a real balance—ease of use, fast handling, low dust, and robust stability under warehouse conditions. Avoiding breakdowns in storage performance is non-negotiable for any material slated for scale-up. Keeping L-Fucose stable means monitoring every lot through temperature and humidity swings, with contingency reserves and rapid-response support channels just in case.

    Those working with animal cell culture or biological assay set-ups expect sterility and uniformity throughout. Cross-contamination threatens entire research cycles, and inadequate preservation can introduce shifts in cellular signals. That’s why customers lean on pre-screened, low endotoxin batches. Our investment in this area ensures that downstream work—whether cell expansion or recombinant protein expression—runs under tightly controlled input materials, reducing risks in biologics scale-up and supporting regulatory filings.

    Supporting Research With More Than Raw Material

    L-Fucose doesn’t simply fill the shelf for chemistry and biology research. Over years of partnership, we’ve helped labs standardize their glycomics workflows and solved recurring analytical puzzles for customer projects. Our direct interaction with users—many facing high-stress validation trials—taught us that accessible technical support and rapid troubleshooting matter as much as the chemical compound itself. There’s a knowledge transfer built into every transaction, with round-the-clock technical staff and open access to process insights. Many customers lean on us for troubleshooting on cell viability shifts, analytical column binding failures, or deviations in colorimetric reactions—real-world feedback forms the backbone of our continuous product tuning.

    Professional reliability comes with staying power, built through years of stable relationships and unswerving support during audits or technical reviews. Whether the end use centers on analytical reference, glycoengineering, or clinical research, our teams walk customers through protocol optimization, regulatory documentation, and change control. We support major method validation exercises, supply guidance for custom packaging or concentration adjustments, and provide substantiated technical details for regulatory meetings. The open technical exchange ensures that product performance—documented and real—stands up to the scrutiny demanded by top-tier customers.

    Responsible Manufacturing and Future Outlook

    Production of L-Fucose ultimately depends on resource management, emission controls, and waste minimization. As a manufacturer rooted in practical experience, we recognize that today’s benchmark is not only purity or physical characteristics, but also responsible sourcing and minimized environmental impact. We continue to invest in cleaner fermentation routes, lower energy input drying systems, and responsible water usage. Waste biomass finds its way into certified recovery streams wherever possible.

    The future of L-Fucose applications keeps expanding. Glycobiology advances pull this humble sugar into new territory, such as immuno-oncology research, engineered probiotics, and specialty nutrition. We field inquiries for applications previously outside our expectations—from modulation of the human gut microbiome to building improved diagnostic biosensors. Our technical teams stay tuned in to new trends, ready to adapt production protocols and purity criteria to incoming requirements.

    Whether a researcher, production engineer, or project manager, seeing smooth progress from delivery to data traces back to fundamental hard work at the manufacturing level. Reliable L-Fucose isn’t an accident. It comes from countless hours of plant tuning, qc expertise, rapid incident response, and a hands-on partnership with end users. Every batch echoes the attention, experience, and dedication of a team who treats every drum and kilo with real commitment. This is how we keep L-Fucose ahead of industry needs—not just as a chemical, but as a real-world tool for innovation.